Prestige Brands completes acquisition of Insight Pharma

• Private equity firm Swander Pace Capital completes its sale of Insight Pharmaceuticals to Prestige Brand Holdings (NYSE:PBH +0.5%) for $750M. The transaction will add ~$800M in pro forma revenues and ~$300M in non-GAAP EBITDA in fiscal 2015. It will be immediately accretive in EPS and FCF.